NETs Get Real with NCAN Liver Directed Therapy with Dr. Charles Nutting!
Oct 9, 2024
Dr. Charles Nutting, an interventional radiologist from Image Guided Therapy in Colorado, shares his expertise on liver-directed therapies for neuroendocrine tumors. He discusses groundbreaking innovations in interventional radiology, including AI integration aimed at minimizing treatment side effects. The conversation delves into the synergy between Peptide Receptor Radionuclide Therapy (PRRT) and liver treatments. Additionally, Dr. Nutting emphasizes the significance of patient involvement in treatment decisions, advocating for informed engagement with specialists.
AI Snips
Chapters
Transcript
Episode notes
Interventional Radiology as a Game
- Dr. Charles Nutting describes his work as playing video games, manipulating tiny catheters inside vessels focused on tumors.
- He uses advanced technology, including AI and GPS-like navigation inside the body for treatment delivery.
How Liver-Directed Therapy Works
- Liver-directed therapy targets tumors specifically through their arterial blood supply using embolization techniques.
- Different embolization types include bland, chemoembolization, and radioembolization with Y90 beads delivering localized radiation.
Sequencing PRRT and Liver Therapy
- PRRT is systemic radiation targeting somatostatin receptor-positive tumors and can be used safely before or after liver-directed therapies.
- Y90 radioembolization is usually reserved for later-stage or aggressive cases to avoid cumulative liver radiation toxicity.